Importance of APPs in Treating and Understanding AD
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
FDA Approves Lebrikizumab-lbkz for Moderate to Severe Atopic Dermatitis
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
POLL: When Do You Escalate AD Treatment if Treatment Targets are Not Achieved?
Journal Digest: September 3